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The exclusion criteria were as follows: concomi‑
tant chronic liver or kidney diseases, collageno‑
ses, thyroid disease, immunosuppressive thera‑
py (during the past 12 months), history of ma‑
lignancy, and acute or chronic inflammatory dis‑
ease (excluded on the basis of medical history, 
medical examination, and determination of se‑
rum C ‑reactive protein levels, which were within 
the reference range in our patients, ie, <5 mg/l). 
Patients with psoriasis were also excluded.1
The study protocol included: 1) a comparative 
analysis of laboratory results in the CAD, PAD, 
and CPAD groups; and 2) evaluation of correla‑
tions between the investigated parameters in 
the CAD, PAD, and CPAD groups.
The study was approved by the local bioethics 
committee. All patients provided their written 
informed consent to blood sampling.
Statistical analysis The Shapiro–Wilk test was 
used to assess the normality of distribution, fol‑
lowed by the calculation of the arithmetic mean 
and standard deviation. The following tests were 
performed: Mann–Whitney test, Spearman cor‑
relation coefficient, Kruskal–Wallis test, t test, 
and 1‑way analysis of variance (ANOVA). Differ‑
ences with a P value of 0.05 or lower were con‑
sidered significant. We revealed differences be‑
tween the mean and median values for a few pa‑
rameters; however, as they were comparable for 
most studied parameters, mean (SD) values were 
calculated in the comparative analysis.
Results and discussion The Kruskal–Wallis test 
revealed that the differences in the mean levels 
of annexin V between the CAD, PAD, and CPAD 
groups approached statistical significance (P = 
Introduction The development of atheroscle‑
rosis is associated not only with endothelial dys‑
function (due to inflammation or injury) and 
subendothelial lesions but also with coagula‑
tion disorders and systemic metabolic abnor‑
malities. However, studies in this area often 
provide inconsistent results. Therefore, we de‑
cided to investigate selected autoimmune mark‑
ers, proteins involved in coagulation, and homo‑
cysteine in patients with atherosclerosis, with 
the aim to identify biomarkers of the risk and 
progression of atherosclerosis.
Methods A total of 78 men and women (age 
range, 54–77 years) diagnosed with atheroscle‑
rosis on the basis of clinical signs and symptoms 
as well as angiography results were divided into 3 
groups: 33 patients with coronary artery disease 
(CAD), 15 patients with peripheral artery disease 
(PAD), and 30 patients with both coronary and 
peripheral artery disease (CPAD). A wide range 
of peripheral blood tests were performed using 
an enzyme ‑linked immunosorbent assay reader 
(µ ‑Quant, BioTek Instruments, Inc., Winooski, 
Vermont, United States). The following parameters 
were determined: 1) blood coagulation—protein 
C, free protein S, and annexin V; 2) autoimmune 
markers—antineutrophil cytoplasmic antibodies 
(pANCAs and cANCAs), antinuclear antibodies 
(ANAs), anti–double ‑stranded DNA (anti ‑dsDNA) 
antibodies, antiendothelial cell antibody (AECA) 
index, anticardiolipin antibodies (ACAs) (immu‑
noglobulins G [IgG] and M [IgM]); and 3) homo‑
cysteine levels to identify metabolic disorders. 
Blood samples were collected between 7:00 and 
8:00 AM, and serum or plasma samples were im‑
mediately coded and stored at –80°C until the assay.
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cANCAs and anti ‑dsDNA antibodies (r = 0.39; 
P = 0.03), ANA and anti ‑dsDNA antibodies 
(r = 0.39; P = 0.03), ANAs and IgG ACAs (r = 0.34; 
P = 0.053), anti ‑dsDNA antibodies and the AECA 
index (r = 0.33; P = 0.061), homocysteine and IgM 
ACAs (r = 0.39; P = 0.02), as well as homocysteine 
and IgG ACAs (r = 0.35; P = 0.04), while negative 
correlations were revealed between the AECA 
index and homocysteine (r = –0.60; P <0.001).
In the PAD group, positive correlations were 
observed between pANCAs and ANAs (r = 0.54; 
P = 0.04), ANAs and anti ‑dsDNA antibodies 
(r = 0.76; P = 0.002), ANAs and IgG ACAs (r = 0.53; 
P = 0.047), as well as anti ‑dsDNA antibodies and 
IgG ACAs (r = 0.60; P = 0.02).
Patients with CAPD had the lowest protein C 
levels in peripheral blood, which might have con‑
tributed to the development and extent of an‑
giopathy; however, the mean protein C concen‑
trations in these patients were within the refer‑
ence range. The PAD group, on the other hand, 
had the lowest free protein S levels (although 
still within the reference range) and the lowest 
annexin V levels.
In the CPAD group, we showed correlations of 
the coagulation components (protein C, protein 
S, and annexin V) with autoimmune parameters 
(cANCAs, AECA index) and homocysteine. How‑
ever, these results are difficult to interpret be‑
cause data on this topic are scarce. Some reports 
have indicated an association between hyper‑
coagulability and the development or progres‑
sion of atherosclerosis.2,3 Interestingly, Vig et al4 
identified thrombophilia in one ‑fourth of their 
study population with PAD. Moreover, plasma 
0.057). The 1‑way ANOVA showed differences in 
protein C levels between the CAD, PAD, and CPAD 
groups (P = 0.02) (Supplementary material, Table S1).
The comparative analysis of laboratory investi‑
gations between the CAD, PAD and CPAD groups 
is presented in TAble 1. In the PAD group, the mean 
protein C level and the AECA index exceeded 
the upper reference limit (6.5 µg/ml and 0.165, 
respectively). In the whole study group, 10 par‑
ticipants (13%) had ANA levels exceeding the up‑
per reference limit (25 AU/ml). The same was ob‑
served for homocysteine levels (>15 µmol/l) in 
17 participants (22%).
In the  CPAD group, more often than in 
the CAD and PAD groups, significant or nearly 
significant inverse correlations were observed 
between the  following parameters:  protein 
C and cANCAs (r = –0.51; P = 0.004), protein S 
and the AECA index (r = –0.36; P = 0.052), annex‑
in V and homocysteine (r = –0.47; P = 0.01), anti‑
‑dsDNA antibodies and homocysteine (r = –0.38; 
P = 0.04), as well as the AECA index and homo‑
cysteine (r = –0.51; P = 0.004). Positive corre‑
lations were shown between protein S and ho‑
mocysteine (r = 0.35; P = 0.058), annexin V and 
the AECA index (r = 0.56; P = 0.002), pANCAs 
and cANCAs (r = 0.50; P = 0.006), pANCAs and 
ANAs (r = 0.42; P = 0.02), pANCAs and IgG ACAs 
(r = 0.48; P = 0.008), cANCAs and ANAs (r = 0.37; 
P = 0.048), cANCAs and IgG ACAs (r = 0.39; 
P = 0.03), ANAs and anti ‑dsDNA antibodies 
(r = 0.55; P = 0.002), as well as anti ‑dsDNA an‑
tibodies and the AECA index (r = 0.31; P = 0.093).
In the CAD group, significant or nearly signif‑
icant positive correlations were noted between 
Table 1 Comparative analysis of protein and homocysteine concentrations in patients with atherosclerosis
Parameter CAD (n = 33) CPAD (n = 30) PAD (n = 15)
Protein C, µg/ml 6.09 (1.97)c 5.00 (1.82)a,b 6.75 (2.66)c
Free protein S, % 129.11 (13.09)b 125.97 (13.06) 121.42 (12.76)a
Annexin V, µg/ml 3.74 (2.03) 4.23 (1.98)b 3.37 (1.94)c
pANCAs, AU/ml 2.81 (1.93) 6.87 (9.73) 3.54 (4.75)
cANCAs, AU/ml 2.61 (2.31) 5.22 (7.56) 4.25 (2.77)
ANAs, AU/ml 17.59 (35.95) 16.44 (15.62)b 8.33 (8.04)c
IgG anti ‑dsDNA antibodies, IU/ml 3.67 (1.35) 3.94 (1.47) 3.50 (1.67)
AECA index 0.04 (0.03) 0.11 (0.32) 0.17 (0.27)
Homocysteine, µmol/l 13.53 (5.95) 12.86 (4.35) 12.49 (4.62)
IgM ACAs, AU/ml 3.49 (0.85) 4.10 (4.40) 7.58 (16.53)
IgG ACAs, AU/ml 3.63 (0.66) 3.80 (1.08) 3.76 (0.76)
Data are presented as mean (SD).
a P ≤0.05 vs CAD; b P ≤0.05 vs PAD; c P ≤0.05 vs CPAD
Abbreviations: ACA, anticardiolipin antibodies; AECA, antiendothelial cell antibodies; ANA, antinuclear antibodies; ANCA, 
antineutrophil cytoplasmic antibodies; anti ‑dsDNA, anti–double ‑stranded DNA; CAD, coronary artery disease; CPAD, coronary and 
peripheral artery disease; CRP, C ‑reactive protein; IgG, immunoglobulin G; IgM, immunoglobulin M; PAD, peripheral artery disease
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and the AECA index. This relationship was also 
revealed in the CPAD group, but not in the PAD 
group. However, it is hard to explain these find‑
ings. It is also difficult to analyze the role of this 
correlation in the pathogenesis of atherosclero‑
sis, particularly because there have not been any 
previous reports on this topic.
In conclusion, our results suggest that autoim‑
munity and homocysteine might be involved in 
the pathogenesis of CAD, PAD, and CPAD in se‑
lected cases. Further studies on larger groups of 
patients are needed to elucidate the correlations 
between the analyzed parameters, observed 
most frequently in patients with CPAD, and to 
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annexin V levels were reported to be inversely 
correlated with the severity of coronary steno‑
sis,5 and patients in the acute phase of myocar‑
dial infarction were shown to have low plasma 
annexin V levels.6
Patients with CPAD also showed correlations 
between ANCAs (both pANCAs and cANCAs) 
and IgG ACAs. These correlations, together with 
the correlations between ANAs and pANCAs in 
the PAD and CPAD groups, between anti ‑dsDNA 
antibodies and cANCAs in the CAD group, and 
between cANCAs and ANAs in the CPAD group, 
seem to provide evidence for a potential associa‑
tion between ANCAs and prothrombotic factors as 
well as between ANAs and anti ‑dsDNA antibodies.
The interest in ANCAs mainly stems from 
their association with vasculitis. Vascular in‑
flammation has been implicated as a causative 
agent in atherosclerosis, and some authors be‑
lieve the inflammatory process to be the pre‑
dominant initiating factor. However, it should 
be noted that a negative ANCA test does not ex‑
clude vasculitis, while positive results do not un‑
equivocally confirm the disease.7
In our study, several individuals with CAD 
and CPAD had ANA levels exceeding the upper 
reference limits. Similar findings were reported 
for the AECA index in the PAD and CPAD groups. 
In addition, we observed a positive correlation 
between the AECA index and anti ‑dsDNA anti‑
bodies in the CAD and CPAD groups. These find‑
ings might suggest some atherosclerosis ‑related 
processes with endothelial involvement and are 
consistent with a higher prevalence of AECAs in 
patients with ischemic heart disease.8
Although the upper reference limits of anti‑
‑dsDNA antibodies, IgG ACAs, pANCAs, and 
cANCAs were not exceeded in our study popula‑
tion, the observed correlations between these an‑
tibodies and ANAs are noteworthy and warrant 
large cohort studies, particularly that the role of 
ANAs in atherogenesis has not been elucidated.
Several participants in each of the groups 
met the criteria for hyperhomocysteinemia. 
The CAD group showed a significant positive 
correlation between IgG and IgM ACAs and ho‑
mocysteine levels, while patients with CPAD 
revealed a negative correlation between homo‑
cysteine and anti ‑dsDNA antibodies. In addi‑
tion, in the PAD group, a positive correlation 
between anti ‑dsDNA antibodies and IgG ACAs 
was observed. Interestingly, some antiphospho‑
lipid antibodies were more prevalent in patients 
in the acute phase of myocardial infarction,9 
which seems to support the concept of immune 
mechanisms and coagulation abnormalities in 
the pathogenesis of atherosclerosis. Homocyste‑
ine and antiphospholipid antibodies exert sim‑
ilar biological effects in hemostasis, but the in‑
teractions between them remain unclear.
Interestingly, the CAD group showed a neg‑
ative correlation between homocysteine levels 
